Levosalbutamol & Ipratropium Bromide Respiratory Solution

About Levosalbutamol & Ipratropium Bromide Respiratory Solution

Description :

Levosalbutamol  Ipratropium Bromide Respiratory Solution is a combination bronchodilator used for the treatment of chronic obstructive pulmonary disease COPD and asthma This solution is designed for inhalation via nebulizer and provides dualaction relief by combining a beta2 agonist Levosalbutamol with a muscarinic antagonist Ipratropium Bromide

It helps open the airways by relaxing the bronchial muscles reducing symptoms such as wheezing chest tightness and breathlessness

Composition per 25 mL unit dose vial

Levosalbutamol Sulphate IP equivalent to Levosalbutamol 125 mg

Ipratropium Bromide IP 500 mcg

Sterile Water for Injection qs to 25 mL

Indications

Chronic Obstructive Pulmonary Disease COPD

Chronic bronchitis

Emphysema

Acute exacerbations of asthma

Key Benefits:

Provides fast and effective bronchodilation

Relieves shortness of breath wheezing and chest tightness

Suitable for use in acute and maintenance therapy

Nebulizerbased delivery ensures deeper lung penetration

Dosage  Administration:

Route Inhalation via nebulizer

Usual Dose One unitdose vial 25 mL inhaled 34 times daily or as directed by a physician

Use with a jet nebulizer connected to an air compressor

Storage Instructions:

Store below 25C in a cool dry place

Protect from light and moisture

Do not freeze

Keep out of reach of children

Caution

Not for injection or oral use

For inhalation use only

Use under medical supervision

Discontinue use and consult your doctor if side effects occur eg rapid heartbeat tremors or dry mouth.